Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
prilocainhydrochlorid 4 % dental type, cylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
prilocainhydrochlorid 1 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
Prilocaine hydrochloride 4% injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
prilocainhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
prilocainhydrochlorid 4 %/adrenalin 200.000 injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
adrenalin 5 µg + prilocainhydrochlorid 40 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
prilocainhydrochlorid 4 % injektionsvæske, opløsning, hætteglas a 1,8 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely prilocaine hydrochloride 80 milligram/2 milliliter conventional release solution for injection cartridge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely prilocaine hydrochloride 80 milligram/2 milliliter conventional release solution for injection cartridge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely felypressin 0.06 unit/2 milliliter and prilocaine hydrochloride 60 milligram/2 milliliter conventional release solution for injection cartridge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely felypressin 0.06 unit/2 milliliter and prilocaine hydrochloride 60 milligram/2 milliliter conventional release solution for injection cartridge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely felypressin 0.03 unit/1 milliliter and prilocaine hydrochloride 30 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely felypressin 0.03 unit/1 milliliter and prilocaine hydrochloride 30 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely prilocaine hydrochloride 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely prilocaine hydrochloride 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely prilocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely prilocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Prilocaine hydrochloride (substance) |
Inferred relationship |
Some |
1 |